Skip to main content

Table 3 Reduction in body weight in Meratrim and placebo groups over 16 week study period

From: Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects

Parameter Reduction Weeks Placebo Meratrim Net reductiona,b P value
(n = 28) (n = 29)
Body weight (kg) 2 0.42 ± 0.18 0.51 ± 0.16 0.09 (0.1 %) 0.749
4 0.64 ± 0.29 1.53 ± 0.20 0.89 (1.2 %) 0.048*
8 1.26 ± 0.40 2.10 ± 0.25 0.84 (1.1 %) 0.190
12 1.19 ± 0.43 3.14 ± 0.28 1.95 (2.6 %) 0.002*
16 1.10 ± 0.46 5.09 ± 0.38 3.99 (5.3 %) <0.0001*
  1. Values represent mean ± SE
  2. *Significant difference between Meratrim and placebo group mean values calculated using ANCOVA with baseline as covariate
  3. aNet reduction = Meratrim minus placebo
  4. bNumbers in parenthesis represents the % net reduction from baseline for Meratrim group